Portfolio company
Carbometrics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops synthetic glucose binding molecules for medical technology manufacturers to improve the accuracy of continuous glucose monitoring systems and metabolic monitors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Phenotap
This company develops enzymes for blood glucose and ketone monitoring device manufacturers to enable continuous metabolic tracking and diabetic ketoacidosis detection.
Synex
This company develops non-invasive wearable sensors to monitor blood metabolites including glucose and lactate for health-conscious consumers and patients.
Sensys
This company develops non-invasive blood glucose monitors using infrared spectroscopy for patients managing diabetes.
Sensible Healthcare Systems
This company develops reusable continuous glucose monitoring sensors for people living with diabetes.
GlucoSet
The company develops an intravascular sensor that provides continuous blood glucose monitoring for critically ill patients in intensive care units.
SynchNeuro
This company develops non-invasive behind-the-ear sensors that decode brain signals to monitor blood glucose and metabolic health for individuals with prediabetes.
Calibra Medical
This company develops wearable, mechanical insulin delivery patches for individuals with type one and type two diabetes to simplify mealtime therapy.
Transdermal Diagnostics
This company develops needle-free, continuous glucose monitoring patches for people living with diabetes and prediabetes to manage blood sugar levels non-invasively.
